Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
As part of its work, the Antibacterial Drug Development Task Force will assist in developing and revising guidance related to antibacterial drug development, as required by regulation signed into law earlier this year. The task force is comprised of 19 scientists and clinicians who will use existing partnerships and collaborations to work with other experts in the field.
More Articles on the FDA:
32 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in August
FDA Launches New Counterfeit Drug Detection Device
Teleflex’s ARROW FlexBlock Received FDA Clearance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
